Haemonetics
HAE
$84.08
Share price
-0.67%
Change (1 day)
-2.88%
Change (1 year)
Categories
Haemonetics (HAE) - Cash on Hand
Cash on Hand as of March 2024 : $0.17 B
According to Haemonetics's latest financial reports the company has $0.17 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Haemonetics - Cash on Hand chart (from 2001 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-03-31 | $0.28 B | 9.62% |
| 2022-03-31 | $0.25 B | 34.94% |
| 2021-03-31 | $0.19 B | 40.05% |
| 2020-03-31 | $0.13 B | -18.92% |
| 2019-03-31 | $0.16 B | -6% |
| 2018-03-31 | $0.18 B | 29.09% |
| 2017-03-31 | $0.13 B | 21.23% |
| 2016-03-31 | $0.11 B | -28.34% |
| 2015-03-31 | $0.16 B | -16.53% |
| 2014-03-31 | $0.19 B | 7.45% |
| 2013-03-31 | $0.17 B | -21.73% |
| 2012-03-31 | $0.22 B | 16.35% |
| 2011-03-31 | $0.19 B | 38.95% |
| 2010-03-31 | $0.14 B | -9.67% |
| 2009-03-31 | $0.15 B | 17.35% |
| 2008-03-31 | $0.13 B | -41.74% |
| 2007-03-31 | $0.22 B | -8.55% |
| 2006-03-31 | $0.25 B | 34.9% |
| 2005-03-31 | $0.18 B | 57.31% |
| 2004-03-31 | $0.11 B | 136.78% |
| 2003-03-31 | $49.88 M | -26.15% |
| 2002-03-31 | $67.54 M | -9.31% |
| 2001-03-31 | $74.48 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $26.21 B | 14,563.31% | 🇺🇸 USA |
 Medtronic MDT | $8.32 B | 4,553.80% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | $7.25 B | 3,954.81% | 🇺🇸 USA |
 Baxter BAX | $3.02 B | 1,592.39% | 🇺🇸 USA |
 Becton Dickinson BDX | $3.17 B | 1,675.73% | 🇺🇸 USA |
 Stryker Corporation SYK | $2.40 B | 1,246.20% | 🇺🇸 USA |
 PerkinElmer
PKI | $2.46 B | 1,276.48% | 🇺🇸 USA |
 Cerus CERS | $72.17 M | -59.63% | 🇺🇸 USA |